The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma

The ALK(F1174L) mutation is associated with intrinsic and acquired resistance to crizotinib and cosegregates with MYCN in neuroblastoma. In this study, we generated a mouse model overexpressing ALK(F1174L) in the neural crest. Compared to ALK(F1174L) and MYCN alone, coexpression of these two oncogen...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Berry, Teeara, Luther, William, Bhatnagar, Namrata, Jamin, Yann, Poon, Evon, Sanda, Takaomi, Pei, Desheng, Sharma, Bandana, Vetharoy, Winston R., Hallsworth, Albert, Ahmad, Zai, Barker, Karen, Moreau, Lisa, Webber, Hannah, Wang, Wenchao, Liu, Qingsong, Perez-Atayde, Antonio, Rodig, Scott, Cheung, Nai-Kong, Raynaud, Florence, Hallberg, Bengt, Robinson, Simon P., Gray, Nathanael S., Pearson, Andrew D.J., Eccles, Suzanne A., Chesler, Louis, George, Rani E.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3417812/
https://ncbi.nlm.nih.gov/pubmed/22789543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2012.06.001
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki